Axios @axios
NEW: FDA advisors voted to recommend that a treatment to prevent women from having preterm births be removed from the market. It's the only drug of its kind in the U.S. and is supported by the leading OB-GYN group. https://t.co/e7zkVqEj9I — PolitiTweet.org